Kholsa Ventures

Drug discovery startup Valo goes public via SPAC merger with Khosla Ventures
By Mallory Hackett | 01:38 pm | June 09, 2021
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.   
Health insurtech company Oscar scores $225M in new funding
By Laura Lovett | 05:20 pm | June 26, 2020
Alphabet, General Catalyst, Kholsa Ventures, Lakestar, Thrive Capital and Baillie Gifford participated in this round.